Application of CD271+ human bone marrow-derived: Stem cells for ischaemic heart disease therapy

Ali Ghodsizad, Mina Farag, Matthias Loebe, Eric Lumsden, Christoph Phiechaczek, Matthias Karck, Arjang Ruhparwar

Research output: Contribution to journalArticle

Abstract

Cell transplantation for myocardial regeneration has been shown to have beneficial effects on cardiac function after myocardial infarction. Here, we discuss the application of CD 271+ bone marrow-derived stem cells (BMCs) as novel markers for the enrichment of mesenchymal somatic stem cells. Injection of BMCs into ischaemic myocardium during surgery has been shown to be both feasible and safe. This novel approach might hold promise as an alternative to medical management in patients with severe ischaemic heart failure who are ineligible for conventional revascularisation.

Original languageEnglish (US)
Pages (from-to)280-282
Number of pages3
JournalEuropean Cardiology
Volume7
Issue number4
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Myocardial Ischemia
Stem Cells
Bone Marrow
Adult Stem Cells
Cell Transplantation
Mesenchymal Stromal Cells
Regeneration
Myocardium
Heart Failure
Myocardial Infarction
Injections
Therapeutics
Adapalene

Keywords

  • Bone marrow-derived stem cells
  • CD 271+
  • Ischaemic heart disease
  • Somatic stem cells
  • Stem cell therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ghodsizad, A., Farag, M., Loebe, M., Lumsden, E., Phiechaczek, C., Karck, M., & Ruhparwar, A. (2011). Application of CD271+ human bone marrow-derived: Stem cells for ischaemic heart disease therapy. European Cardiology, 7(4), 280-282.

Application of CD271+ human bone marrow-derived : Stem cells for ischaemic heart disease therapy. / Ghodsizad, Ali; Farag, Mina; Loebe, Matthias; Lumsden, Eric; Phiechaczek, Christoph; Karck, Matthias; Ruhparwar, Arjang.

In: European Cardiology, Vol. 7, No. 4, 06.2011, p. 280-282.

Research output: Contribution to journalArticle

Ghodsizad, A, Farag, M, Loebe, M, Lumsden, E, Phiechaczek, C, Karck, M & Ruhparwar, A 2011, 'Application of CD271+ human bone marrow-derived: Stem cells for ischaemic heart disease therapy', European Cardiology, vol. 7, no. 4, pp. 280-282.
Ghodsizad A, Farag M, Loebe M, Lumsden E, Phiechaczek C, Karck M et al. Application of CD271+ human bone marrow-derived: Stem cells for ischaemic heart disease therapy. European Cardiology. 2011 Jun;7(4):280-282.
Ghodsizad, Ali ; Farag, Mina ; Loebe, Matthias ; Lumsden, Eric ; Phiechaczek, Christoph ; Karck, Matthias ; Ruhparwar, Arjang. / Application of CD271+ human bone marrow-derived : Stem cells for ischaemic heart disease therapy. In: European Cardiology. 2011 ; Vol. 7, No. 4. pp. 280-282.
@article{dc5254c5208e4b26bc1478a39d3d3b0f,
title = "Application of CD271+ human bone marrow-derived: Stem cells for ischaemic heart disease therapy",
abstract = "Cell transplantation for myocardial regeneration has been shown to have beneficial effects on cardiac function after myocardial infarction. Here, we discuss the application of CD 271+ bone marrow-derived stem cells (BMCs) as novel markers for the enrichment of mesenchymal somatic stem cells. Injection of BMCs into ischaemic myocardium during surgery has been shown to be both feasible and safe. This novel approach might hold promise as an alternative to medical management in patients with severe ischaemic heart failure who are ineligible for conventional revascularisation.",
keywords = "Bone marrow-derived stem cells, CD 271+, Ischaemic heart disease, Somatic stem cells, Stem cell therapy",
author = "Ali Ghodsizad and Mina Farag and Matthias Loebe and Eric Lumsden and Christoph Phiechaczek and Matthias Karck and Arjang Ruhparwar",
year = "2011",
month = "6",
language = "English (US)",
volume = "7",
pages = "280--282",
journal = "European Cardiology Review",
issn = "1758-3756",
publisher = "Radcliffe Publishing Ltd.",
number = "4",

}

TY - JOUR

T1 - Application of CD271+ human bone marrow-derived

T2 - Stem cells for ischaemic heart disease therapy

AU - Ghodsizad, Ali

AU - Farag, Mina

AU - Loebe, Matthias

AU - Lumsden, Eric

AU - Phiechaczek, Christoph

AU - Karck, Matthias

AU - Ruhparwar, Arjang

PY - 2011/6

Y1 - 2011/6

N2 - Cell transplantation for myocardial regeneration has been shown to have beneficial effects on cardiac function after myocardial infarction. Here, we discuss the application of CD 271+ bone marrow-derived stem cells (BMCs) as novel markers for the enrichment of mesenchymal somatic stem cells. Injection of BMCs into ischaemic myocardium during surgery has been shown to be both feasible and safe. This novel approach might hold promise as an alternative to medical management in patients with severe ischaemic heart failure who are ineligible for conventional revascularisation.

AB - Cell transplantation for myocardial regeneration has been shown to have beneficial effects on cardiac function after myocardial infarction. Here, we discuss the application of CD 271+ bone marrow-derived stem cells (BMCs) as novel markers for the enrichment of mesenchymal somatic stem cells. Injection of BMCs into ischaemic myocardium during surgery has been shown to be both feasible and safe. This novel approach might hold promise as an alternative to medical management in patients with severe ischaemic heart failure who are ineligible for conventional revascularisation.

KW - Bone marrow-derived stem cells

KW - CD 271+

KW - Ischaemic heart disease

KW - Somatic stem cells

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=84856112998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856112998&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84856112998

VL - 7

SP - 280

EP - 282

JO - European Cardiology Review

JF - European Cardiology Review

SN - 1758-3756

IS - 4

ER -